ICON prices $2.15B in notes to refinance secured debt
What's the deal? ICON plcDealroom has a profile for this one. Try Dealroom → (NASDAQ: ICLR), the Ireland-based clinical research organisation, has priced $2.15 billion in senior unsecured notes through its wholly owned subsidiary, ICON Investments Six Designated Activity CompanyDealroom has a profile for this one. Try Dealroom →. The offering is expected to close on 13 August 2026, subject to customary closing conditions.
The structure. The deal spans three tranches: $500 million of 5.064% notes due 2029, $1 billion of 5.421% notes due 2031, and $650 million of 5.995% notes due 2036. All will be guaranteed on a senior unsecured basis by ICON.
What's the money for? ICON plans to use the net proceeds to repay outstanding borrowings under its bridge facility, repay its senior secured term loans, and redeem in full its 5.809% Senior Secured Notes due 2027.
Why it matters. The refinancing shifts ICON from secured to unsecured debt. Once the bridge facility and term loans are repaid, collateral securing the revolving credit facility and existing notes will be released automatically, along with related subsidiary guarantees.
Where it lands. The notes are being offered to qualified institutional buyers under Rule 144A and outside the US under Regulation S, and have not been registered under the Securities Act.
The signal. At $2.15 billion, this is among the largest post-IPO debt raises for a health company based in Ireland. It marks a move to simplify ICON's capital structure and trade secured obligations for unsecured ones.
Read more: StreetInsider
Image credit: Generated with Gemini
